Легочное кровотечение в практике ревматолога

1. Ibrahim WH. Massive haemoptysis: the definition should be revised. Eur Respir J. 2008;32(4):1131-2. doi: 10.1183/09031936.00080108
2. Palade E, Guenter J, Elze M, Wiesemann S, Passlick B. Management of Hemoptysis: Results of an Algorithm-Based Interdisciplinary Treatment Scheme. Zentralbl Chir. 2016;141(1):85-92. doi: 10.1055/s-0035-1545877
3. Swanson KL, Johnson M, Prakash UBS, et al. Bronchial artery embolization: experience with 54 patients. Chest. 2002;121:789-95.
4. Bruzzi JF, Rémy-Jardin M, Delhaye D, Teisseire A, Khalil C, Rémy J. Multi-detector row CT of hemoptysis. Radiographics. 2006;26(1):3-22. doi: 10.11 48/rg.261045726
5. Yoon YC, Lee KS, Jeong YJ, Shin SW, Chung MJ, Kwon OJ. Hemoptysis: bronchial and nonbronchial systemic arteries at 16-detector row CT. Radiology. 2005;234(1):292-8. doi: 10.1148/radiol.2341032079
6. Revel MP, Fournier LS, Hennebicque AS, Cuenod CA, Meyer G, Reynaud P, Frija G. Can CT replace bronchoscopy in the detection of the site and cause of bleeding in patients with large or massive hemoptysis? AJR Am J Roentgenol. 2002;179(5):1217-24. doi: 10.2214/ajr.179.5.1791217
7. Hsiao EI, Kirsch CM, Kagawa FT, Wehner JH, Jensen WA, Baxter RB. Utility of fiberoptic bronchoscopy before bronchial artery embolization for massive hemoptysis. AJR Am J Roentgenol. 2001;177(4):861-7. doi: 10.2214/ajr.177.4.17 70861
8. Fishbein GA, Fishbein MC. Lung vasculitis and alveolar hemorrhage: Pathology. Semin Respir Crit Care Med. 2011;32:254-63. doi: 10.1055/s-0031-1279823
9. Cordier JF, Cottin V. Alveolar hemorrhage in vasculitis: Primary and secondary. Semin Respir Crit Care Med. 2011;32(3):310-21. doi: 10.1055/s-0031-1279827
10. Krause ML, Cartin-Ceba R, Specks U, Peikert T. Update on diffuse alveolar hemorrhage and pulmonary vasculitis. Immunol Allergy Clin North Am. 2012;32(4):587-600. doi: 10.1016/j.iac.2012.08.001
11. Nasser M, Cottin V. Alveolar hemorrhage in vasculitis (primary and secondary). Semin Respir Crit Care Med. 2018;39(4):482-93. doi: 10.1055/s-0038-1668533
12. Quadrelli S, Dubinsky D, Solis M, et al. Immune diffuse alveolar hemorrhage: clinical presentation and outcome. Respir Med. 2017;129:59-62. doi: 10.1016/j.rmed.2017.06.003
13. Papiris SA, Manali ED, Kalomenidis I, Kapotsis GE, Karakatsani A, Roussos C. Bench-to-bedside review: pulmonary-renal syndromes--an update for the intensivist. Crit Care. 2007;11(3):213. doi: 10.1186/cc5778
14. Lazar R. Alveolar hemorrhage syndromes. Eur Respir Mon. 2011;54:15-31.
15. Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, Hoffman GS, Jayne DR, Kallenberg CG, Lamprecht P, Langford CA, Luqmani RA, Mahr AD, Matteson EL, Merkel PA, Ozen S, Pusey CD, Rasmussen N, Rees AJ, Scott DG, Specks U, Stone JH, Takahashi K, Watts RA. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013;65(1):1-11. doi: 10.1002/art.37715
16. Бекетова Т.В. Алгоритм диагностики системных васкулитов, ассоциированных с антинейтрофильными цитоплазматическими антителами. Терапевтический архив. 2018;90(5):13-21 [Beketova TV. Diagnostic algorithm for antineutrophil cytoplasmic antibody-associated systemic vasculitis. Therapeutic Archive. 2018;90(5):13-21 (In Russ.)].
17. Cartin-Ceba R, Diaz-Caballero L, Al-Qadi MO, et al. Diffuse alveolar hemorrhage secondary to antineutrophil cytoplasmic antibody-associated vasculitis: predictors of respiratory failure and clinical outcomes. Arthritis Rheumatol. 2016;68(06):1467-76. doi: 10.1002/art.39562
18. Pedchenko V, Bondar O, Fogo AV, et al. Molecular architecture of the Gudpasture autoantigen in anti-GBM nephritis. N Engl J Med. 2010;363:343-54. doi: 10.1056/NEJMoa0910500
19. Lazor R, Bigay-Game L, Cottin V, et al. Alveolar hemorrhage in anti-basement membrane antibody disease: a series of 28 cases. Medicine (Baltimore). 2007;86:181-93. doi: 10.1097/md.0b013e318067da56
20. Short AK, Esnault VL, Lockwood CM. Anti-neutrophil cytoplasm antibodies and anti-glomerular basement membrane antibodies: two coexisting distinct autoreactivities detectable in patients with rapidly progressive glomerulonephritis. Am J Kidney Dis. 1995;26:439-45.
21. Levy JB, Turner AN, Rees AJ, et al. Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression. Ann Intern Med. 2001;134:1033-42.
22. Zamora MR, Warner ML, Tuder R, Schwarz MI. Diffuse alveolar hemorrhage and systemic lupus erythematosus. Clinical presentation, histology, survival, and outcome. Medicine (Baltimore). 1997;76(3):192-202.
23. Andrade C, Mendoca T, Farinha F, et al. Alveolar hemorrhage in systemic lupus erythematosus: A cohort review. Lupus. 2016;25(1):75-80. doi: 10.1177/ 0961203315605365
24. Singla S, Canter DL, Vece TJ, et al. Diffuse alveolar hemorrhage as a manifestation of childhood-onset systemic lupus erythematosus. Hosp Pediatr. 2016;6(8):496-500. doi: 10.1542/hpeds.2015-0281
25. Kim D, Choi J, Cho SK, et al. Clinical characteristics and outcomes of diffuse alveolar hemorrhage in patients with systemic lupus erythematosus. Semin Arthritis Rheum. 2017;46(6):782-7. doi: 10.1016/j.semarthrit.2016.09.004
26. Kazzaz NM, Coit P, Lewis EE, et al. Systemic lupus erythematosus complicated by diffuse alveolar hemorrhage: Risk factors, therapy and survival. Lupus Sci Med. 2015;2(1):e000117. doi: 10.1136/lupus-2015-000117
27. Mittoo S, Fell CD. Pulmonary manifestation of systemic lupus erythematosus. Semin Respir Crit Care Med. 2014;35(2):249-54. doi: 10.1055/s-0034-1371537
28. Ednalino C, Yip J, Carsons SE. Systematic review of diffuse alveolar hemorrhage in systemic lupus erythematosus: Focus on outcome and therapy. J Clin Rheumatol. 2015;21(6):305-10. doi: 10.1097/RHU.0000000000000291
29. Kwok SK, Moon SJ, Lu JH, et al. Diffuse alveolar hemorrhage in systemic lupus erythematosus: risk factors and clinical outcome: Results from affiliated hospitals of Catholic University of Korea. Lupus. 2011;20(1):102-7. doi: 10.1177/0961203310381511
30. Picard C, Cadranel J, Porcher R, et al. Alveolar hemorrhage in the immunocompetent host: a scale for early diagnosis of immune cause. Respiration. 2010;80:313-20. doi: 10.1159/000315144
31. Rabe C, Appenrodt B, Hoff C, et al. Severe respiratory failure due to diffuse alveolar hemorrhage: clinical characteristics and outcome of intensive care. J Crit Care. 2010;25(2):230-5. doi: 10.1016/j.jcrc.2009.04.009
32. Jin SM, Yim JJ, Yoo CG, et al. Aetiologies and outcomes of diffuse alveolar hemorrhage presenting as acute respiratory failure of uncertain cause. Respirology. 2009;14:290-4. doi: 10.1111/j.1440-1843.2008.01444.x
33. De Prost N, Parrot A, Picard C, et al. Diffuse alveolar haemorrhage: factors associated with in-hospital and long-term mortality. Eur Respir J. 2010; 35(6):1303-11. doi: 10. 1183/09031936.00075309
34. Schwartz R, Myerson RM, LawrenceT, et al. Mitral stenosis, massive pulmonary hemorrhage, and emergency valve replacement. N Eng J Med. 1966; 275:755-8. doi: 10.1056/NEJM196610062751404
35. West JB, Mthieu-Costello O. Volnerability of pulmonary capillaries in heart disease. Circulation. 1995;92:622-31.
36. Spence TH, Connors JC. Diffuse alveolar hemorrhage syndrome due to "silent" mitral valve regurgitation. South Med J. 2000;93:65-7.
37. Насонов Е.Л., редактор. Российские клинические рекомендации. Ревматология. М.: ГЭОТАР-Медиа, 2019:464 [Nasonov EL, editor. Russian clinical guidelines. Rheumatology. Moscow: GEOTAR-media, 2019:464 p. (In Russ.)]. ISBN: 978-5-9704-4816-8
38. Abal AT, Nair PC, Cherian J. Haemoptysis: aetiology, evaluation and outcome — aprospective study in a third-world country. Respir Med. 2001;95(7):548-52. doi: 10.1053/rmed.2001.1053
39. Gillet Y, Issartel B, Vanhems P, et al. Association between Staphylococcus aureus strains carrying gene for Pantone-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet. 2002;359:753-9. doi: 10.1016/S0140-6736(02)07877-7
40. Boussaud V, Parrot A, Mayaud C, et al. Life-threatening hemoptysis in adults with community-acquired pneumonia due to Panton-Valentine leukocidin-secreting Staphylococcus aureus. Intensive Care Med. 2003;29:1840-3. doi: 10.1007/s00134-003-1918-5
41. Johnson V, Stockley JM, Dockrell D, et al. Fever in returned travellers presenting in the United Kingdom: recommendations for investigation and initial management. J Infect. 2009;59:1-18. doi: 10.1016/j.jinf.2009.05.005
42. Damoiseaux J, et al. EUROPLUS ANCA BIOCHIP mosaic: PR3 and MPO antigen microdots improve the laboratory diagnostics of ANCA-associated vasculitis. J Immunol Methods. 2009;348(1–2):67-73. doi: 10.1016/j.jim.2009.07.0 01
43. Марченков Ю.В., Яковлев В.Н., Коржева И.Ю., Алексеев В.Г., Мороз В.В. Алгоритмы диагностики и лечения легочных кровотечений. Общая реаниматология. 2013;9(2):45 [Marchenkov YuV, Yakovlev VN, Korzheva IYu, Alekseyev VG, Moroz VV. Algorithms for the Diagnosis and Treatment of Pulmonary Hemorrhage. General Reanimatology. 2013;9(2):45-54 (In Russ.)]. doi.org/10.15360/1813-9779-2013-2-45
44. Johnson JP, Moore J Jr, Austin HR 3rd, et al. Therapy of anti-glomerular basement membrane antibody disease: analysis of prognostic significance of clinical, pathologic and treatment factors. Medicine (Baltimore). 1985;64:219-27.
45. Betensley AD, Yankaskas JR. Factor VIIA for alveolar hemorrhage in microscopic polyangiitis. Am J Respir Crit Care Med. 2002;166(9):1291-2. doi: 10.1164/ajrccm.166.9.267d
46. Henke D, Falk RJ, Gabriel DA. Successful treatment of diffuse alveolar hemorrhage with activated factor VII. Ann Intern Med. 2004;140(6):493-4.
47. Pathak V, Kuhn J, Gabriel D, Barrow J, Jennette JC, Henke DC. Use of activated factor VII in patients with diffuse alveolar hemorrhage: A 10 years institutional experience. Lung. 2015;193(3):375-9. doi: 10.1007/s00408-015-9720-z
48. Baker MC, Diab KJ, Carlos WJ, Mathur P. Intrapulmonary recombinant factor VII as an effective treatment for diffuse alveolar hemorrhage: A case series. J Bronchology Interv Pulmonol. 2016;23(3):255-8. doi: 10.1097/LBR.0000000000 000286
49. Schmidt M, Bailey M, Sheldrake J, Hodgson C, Aubron C, Rycus PT, Scheinkestel C, Cooper DJ, Brodie D, Pellegrino V, Combes A, Pilcher D. Predicting survival after extracorporeal membrane oxygenation for severe acute respiratory failure. The Respiratory Extracorporeal Membrane Oxygenation Survival Prediction (RESP) score. Am J Respir Crit Care Med. 2014;189:1374-82. doi: 10.1164/rccm.201311-2023OC
50. Yusuff H, Malagon I, Robson K, Parmar J, Hamilton P, Falter F. Extracorporeal membrane oxygenation for life-threatening ANCA-positive pulmonary capillaritis. A review of UK experience. Heart Lung Vessel. 2015; 7(2):159-67.
51. Лысенко М.А., Фролова Н.Ф., Кецкало М.В., Дьякова Е.Н., Сысоева И.Л., Жилинская Т.Р., Котенко О.Н., Волгина Г.В. Экстракорпоральная мембранная оксигенация при жизнеугрожающем ANCA-позитивном диффузном некротизирующем геморрагическом альвеолите. Клиническая нефрология. 2018;3:57-62 [Lysenko MA, Frolova NF, Ketskalo MV, Dyakova EN, Sysoeva IL, Zhilinskaya TR, Kotenko ON, Volgina GV. Extracorporeal membrane oxygenation in life-threatening ANCA-positive diffuse necrotizing alveolar hemorrhage. Clinical nephrology. 2018;3:57-62 (In Russ.)]. doi: https://dx.doi. org/10.18565/nephrology.2018.3.57-62
52. Булач Т.П., Ершов А.Л. Подходы к выбору стратегии респираторной поддержки при респираторном дистресс-синдроме взрослых (научный обзор). Профилактическая и клиническая медицина. 2017;4(65):35-40 [Bulach TP, Ershov AL. Choosing approaches to respiratory support strategy in adult respiratory distress syndrome (scientific review). Preventive and clinical medicine. 2017;4(65):35-40 (In Russ.)].
53. Левин А.В., Цеймах Е.А., Ананко О.Н. и др. Применение клапанной бронхоблокации у больных с легочным кровотечением при распространенном туберкулезе. Грудная и сердечно-сосудистая хирургия. 2005;(3):39-43 [Levin AV, Tseimakh EA, Pletnev GV, Ananko ON, Deyev TI, Zimonin PE. Use of valve bronchoblocation in patients with pulmonary hemorrhage in disseminated tuberculosis. Russian journal of thoracic an cardiovascular surgery. 2005;(3):39-43(In Russ.)].
54. Hayakawa K, Tanaka F, Torizuka T, Mitsumori M, Okuno Y, Matsui A, Satoh Y, Fujiwara K, Misaki T. Bronchial artery embolization for hemoptysis: immediate and long-term results. Cardiovasc Intervent Radiol. 1992;15(3):154-8.
55. Tamashiro A, Miceli MH, Rando C, Tamashiro GA, Villegas MO, Dini AE, Balestrin AE, Diaz JA. Pulmonary artery access embolization in patients with massive hemoptysis in whom bronchial and/or non bronchial systemic artery embolization is contraindicated. Cardiovasc Intervent Radiol. 2008;31(3): 633-7. doi: 10.1007/s00270-007-9265-5
56. Ramakantan R, Bandekar VG, Gandhi MS, Aulakh BG, Deshmukh HL. Massive hemoptysis due to pulmonary tuberculosis: control with bronchial artery embolization. Radiology. 1996;200(3):691-4. doi: 10.1148/radiology.200.3.87569 16
57. Mesurolle B, Lacombe P, Barre O, Qanadli S, Mulot RO, Chagnon S. [Failures and complications of bronchial artery embolization]. Rev Mal Respir. 1996;13(3):217-25. 

________________________________________________

1. Ibrahim WH. Massive haemoptysis: the definition should be revised. Eur Respir J. 2008;32(4):1131-2. doi: 10.1183/09031936.00080108
2. Palade E, Guenter J, Elze M, Wiesemann S, Passlick B. Management of Hemoptysis: Results of an Algorithm-Based Interdisciplinary Treatment Scheme. Zentralbl Chir. 2016;141(1):85-92. doi: 10.1055/s-0035-1545877
3. Swanson KL, Johnson M, Prakash UBS, et al. Bronchial artery embolization: experience with 54 patients. Chest. 2002;121:789-95.
4. Bruzzi JF, Rémy-Jardin M, Delhaye D, Teisseire A, Khalil C, Rémy J. Multi-detector row CT of hemoptysis. Radiographics. 2006;26(1):3-22. doi: 10.11 48/rg.261045726
5. Yoon YC, Lee KS, Jeong YJ, Shin SW, Chung MJ, Kwon OJ. Hemoptysis: bronchial and nonbronchial systemic arteries at 16-detector row CT. Radiology. 2005;234(1):292-8. doi: 10.1148/radiol.2341032079
6. Revel MP, Fournier LS, Hennebicque AS, Cuenod CA, Meyer G, Reynaud P, Frija G. Can CT replace bronchoscopy in the detection of the site and cause of bleeding in patients with large or massive hemoptysis? AJR Am J Roentgenol. 2002;179(5):1217-24. doi: 10.2214/ajr.179.5.1791217
7. Hsiao EI, Kirsch CM, Kagawa FT, Wehner JH, Jensen WA, Baxter RB. Utility of fiberoptic bronchoscopy before bronchial artery embolization for massive hemoptysis. AJR Am J Roentgenol. 2001;177(4):861-7. doi: 10.2214/ajr.177.4.17 70861
8. Fishbein GA, Fishbein MC. Lung vasculitis and alveolar hemorrhage: Pathology. Semin Respir Crit Care Med. 2011;32:254-63. doi: 10.1055/s-0031-1279823
9. Cordier JF, Cottin V. Alveolar hemorrhage in vasculitis: Primary and secondary. Semin Respir Crit Care Med. 2011;32(3):310-21. doi: 10.1055/s-0031-1279827
10. Krause ML, Cartin-Ceba R, Specks U, Peikert T. Update on diffuse alveolar hemorrhage and pulmonary vasculitis. Immunol Allergy Clin North Am. 2012;32(4):587-600. doi: 10.1016/j.iac.2012.08.001
11. Nasser M, Cottin V. Alveolar hemorrhage in vasculitis (primary and secondary). Semin Respir Crit Care Med. 2018;39(4):482-93. doi: 10.1055/s-0038-1668533
12. Quadrelli S, Dubinsky D, Solis M, et al. Immune diffuse alveolar hemorrhage: clinical presentation and outcome. Respir Med. 2017;129:59-62. doi: 10.1016/j.rmed.2017.06.003
13. Papiris SA, Manali ED, Kalomenidis I, Kapotsis GE, Karakatsani A, Roussos C. Bench-to-bedside review: pulmonary-renal syndromes--an update for the intensivist. Crit Care. 2007;11(3):213. doi: 10.1186/cc5778
14. Lazar R. Alveolar hemorrhage syndromes. Eur Respir Mon. 2011;54:15-31.
15. Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, Hoffman GS, Jayne DR, Kallenberg CG, Lamprecht P, Langford CA, Luqmani RA, Mahr AD, Matteson EL, Merkel PA, Ozen S, Pusey CD, Rasmussen N, Rees AJ, Scott DG, Specks U, Stone JH, Takahashi K, Watts RA. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013;65(1):1-11. doi: 10.1002/art.37715
16. Beketova TV. Diagnostic algorithm for antineutrophil cytoplasmic antibody-associated systemic vasculitis. Therapeutic Archive. 2018;90(5):13-21 (In Russ.).
17. Cartin-Ceba R, Diaz-Caballero L, Al-Qadi MO, et al. Diffuse alveolar hemorrhage secondary to antineutrophil cytoplasmic antibody-associated vasculitis: predictors of respiratory failure and clinical outcomes. Arthritis Rheumatol. 2016;68(06):1467-76. doi: 10.1002/art.39562
18. Pedchenko V, Bondar O, Fogo AV, et al. Molecular architecture of the Gudpasture autoantigen in anti-GBM nephritis. N Engl J Med. 2010;363:343-54. doi: 10.1056/NEJMoa0910500
19. Lazor R, Bigay-Game L, Cottin V, et al. Alveolar hemorrhage in anti-basement membrane antibody disease: a series of 28 cases. Medicine (Baltimore). 2007;86:181-93. doi: 10.1097/md.0b013e318067da56
20. Short AK, Esnault VL, Lockwood CM. Anti-neutrophil cytoplasm antibodies and anti-glomerular basement membrane antibodies: two coexisting distinct autoreactivities detectable in patients with rapidly progressive glomerulonephritis. Am J Kidney Dis. 1995;26:439-45.
21. Levy JB, Turner AN, Rees AJ, et al. Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression. Ann Intern Med. 2001;134:1033-42.
22. Zamora MR, Warner ML, Tuder R, Schwarz MI. Diffuse alveolar hemorrhage and systemic lupus erythematosus. Clinical presentation, histology, survival, and outcome. Medicine (Baltimore). 1997;76(3):192-202.
23. Andrade C, Mendoca T, Farinha F, et al. Alveolar hemorrhage in systemic lupus erythematosus: A cohort review. Lupus. 2016;25(1):75-80. doi: 10.1177/ 0961203315605365
24. Singla S, Canter DL, Vece TJ, et al. Diffuse alveolar hemorrhage as a manifestation of childhood-onset systemic lupus erythematosus. Hosp Pediatr. 2016;6(8):496-500. doi: 10.1542/hpeds.2015-0281
25. Kim D, Choi J, Cho SK, et al. Clinical characteristics and outcomes of diffuse alveolar hemorrhage in patients with systemic lupus erythematosus. Semin Arthritis Rheum. 2017;46(6):782-7. doi: 10.1016/j.semarthrit.2016.09.004
26. Kazzaz NM, Coit P, Lewis EE, et al. Systemic lupus erythematosus complicated by diffuse alveolar hemorrhage: Risk factors, therapy and survival. Lupus Sci Med. 2015;2(1):e000117. doi: 10.1136/lupus-2015-000117
27. Mittoo S, Fell CD. Pulmonary manifestation of systemic lupus erythematosus. Semin Respir Crit Care Med. 2014;35(2):249-54. doi: 10.1055/s-0034-1371537
28. Ednalino C, Yip J, Carsons SE. Systematic review of diffuse alveolar hemorrhage in systemic lupus erythematosus: Focus on outcome and therapy. J Clin Rheumatol. 2015;21(6):305-10. doi: 10.1097/RHU.0000000000000291
29. Kwok SK, Moon SJ, Lu JH, et al. Diffuse alveolar hemorrhage in systemic lupus erythematosus: risk factors and clinical outcome: Results from affiliated hospitals of Catholic University of Korea. Lupus. 2011;20(1):102-7. doi: 10.1177/0961203310381511
30. Picard C, Cadranel J, Porcher R, et al. Alveolar hemorrhage in the immunocompetent host: a scale for early diagnosis of immune cause. Respiration. 2010;80:313-20. doi: 10.1159/000315144
31. Rabe C, Appenrodt B, Hoff C, et al. Severe respiratory failure due to diffuse alveolar hemorrhage: clinical characteristics and outcome of intensive care. J Crit Care. 2010;25(2):230-5. doi: 10.1016/j.jcrc.2009.04.009
32. Jin SM, Yim JJ, Yoo CG, et al. Aetiologies and outcomes of diffuse alveolar hemorrhage presenting as acute respiratory failure of uncertain cause. Respirology. 2009;14:290-4. doi: 10.1111/j.1440-1843.2008.01444.x
33. De Prost N, Parrot A, Picard C, et al. Diffuse alveolar haemorrhage: factors associated with in-hospital and long-term mortality. Eur Respir J. 2010; 35(6):1303-11. doi: 10. 1183/09031936.00075309
34. Schwartz R, Myerson RM, LawrenceT, et al. Mitral stenosis, massive pulmonary hemorrhage, and emergency valve replacement. N Eng J Med. 1966; 275:755-8. doi: 10.1056/NEJM196610062751404
35. West JB, Mthieu-Costello O. Volnerability of pulmonary capillaries in heart disease. Circulation. 1995;92:622-31.
36. Spence TH, Connors JC. Diffuse alveolar hemorrhage syndrome due to "silent" mitral valve regurgitation. South Med J. 2000;93:65-7.
37. Nasonov EL, editor. Russian clinical guidelines. Rheumatology. Moscow: GEOTAR-media, 2019:464 p. (In Russ.). ISBN: 978-5-9704-4816-8
38. Abal AT, Nair PC, Cherian J. Haemoptysis: aetiology, evaluation and outcome — aprospective study in a third-world country. Respir Med. 2001;95(7):548-52. doi: 10.1053/rmed.2001.1053
39. Gillet Y, Issartel B, Vanhems P, et al. Association between Staphylococcus aureus strains carrying gene for Pantone-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet. 2002;359:753-9. doi: 10.1016/S0140-6736(02)07877-7
40. Boussaud V, Parrot A, Mayaud C, et al. Life-threatening hemoptysis in adults with community-acquired pneumonia due to Panton-Valentine leukocidin-secreting Staphylococcus aureus. Intensive Care Med. 2003;29:1840-3. doi: 10.1007/s00134-003-1918-5
41. Johnson V, Stockley JM, Dockrell D, et al. Fever in returned travellers presenting in the United Kingdom: recommendations for investigation and initial management. J Infect. 2009;59:1-18. doi: 10.1016/j.jinf.2009.05.005
42. Damoiseaux J, et al. EUROPLUS ANCA BIOCHIP mosaic: PR3 and MPO antigen microdots improve the laboratory diagnostics of ANCA-associated vasculitis. J Immunol Methods. 2009;348(1–2):67-73. doi: 10.1016/j.jim.2009.07.0 01
43. Marchenkov YuV, Yakovlev VN, Korzheva IYu, Alekseyev VG, Moroz VV. Algorithms for the Diagnosis and Treatment of Pulmonary Hemorrhage. General Reanimatology. 2013;9(2):45-54 (In Russ.). doi.org/10.15360/1813-9779-2013-2-45
44. Johnson JP, Moore J Jr, Austin HR 3rd, et al. Therapy of anti-glomerular basement membrane antibody disease: analysis of prognostic significance of clinical, pathologic and treatment factors. Medicine (Baltimore). 1985;64:219-27.
45. Betensley AD, Yankaskas JR. Factor VIIA for alveolar hemorrhage in microscopic polyangiitis. Am J Respir Crit Care Med. 2002;166(9):1291-2. doi: 10.1164/ajrccm.166.9.267d
46. Henke D, Falk RJ, Gabriel DA. Successful treatment of diffuse alveolar hemorrhage with activated factor VII. Ann Intern Med. 2004;140(6):493-4.
47. Pathak V, Kuhn J, Gabriel D, Barrow J, Jennette JC, Henke DC. Use of activated factor VII in patients with diffuse alveolar hemorrhage: A 10 years institutional experience. Lung. 2015;193(3):375-9. doi: 10.1007/s00408-015-9720-z
48. Baker MC, Diab KJ, Carlos WJ, Mathur P. Intrapulmonary recombinant factor VII as an effective treatment for diffuse alveolar hemorrhage: A case series. J Bronchology Interv Pulmonol. 2016;23(3):255-8. doi: 10.1097/LBR.0000000000 000286
49. Schmidt M, Bailey M, Sheldrake J, Hodgson C, Aubron C, Rycus PT, Scheinkestel C, Cooper DJ, Brodie D, Pellegrino V, Combes A, Pilcher D. Predicting survival after extracorporeal membrane oxygenation for severe acute respiratory failure. The Respiratory Extracorporeal Membrane Oxygenation Survival Prediction (RESP) score. Am J Respir Crit Care Med. 2014;189:1374-82. doi: 10.1164/rccm.201311-2023OC
50. Yusuff H, Malagon I, Robson K, Parmar J, Hamilton P, Falter F. Extracorporeal membrane oxygenation for life-threatening ANCA-positive pulmonary capillaritis. A review of UK experience. Heart Lung Vessel. 2015; 7(2):159-67.
51. Lysenko MA, Frolova NF, Ketskalo MV, Dyakova EN, Sysoeva IL, Zhilinskaya TR, Kotenko ON, Volgina GV. Extracorporeal membrane oxygenation in life-threatening ANCA-positive diffuse necrotizing alveolar hemorrhage. Clinical nephrology. 2018;3:57-62 (In Russ.). doi: https://dx.doi. org/10.18565/nephrology.2018.3.57-62
52. Bulach TP, Ershov AL. Choosing approaches to respiratory support strategy in adult respiratory distress syndrome (scientific review). Preventive and clinical medicine. 2017;4(65):35-40 (In Russ.).
53. Levin AV, Tseimakh EA, Pletnev GV, Ananko ON, Deyev TI, Zimonin PE. Use of valve bronchoblocation in patients with pulmonary hemorrhage in disseminated tuberculosis. Russian journal of thoracic an cardiovascular surgery. 2005;(3):39-43(In Russ.).
54. Hayakawa K, Tanaka F, Torizuka T, Mitsumori M, Okuno Y, Matsui A, Satoh Y, Fujiwara K, Misaki T. Bronchial artery embolization for hemoptysis: immediate and long-term results. Cardiovasc Intervent Radiol. 1992;15(3):154-8.
55. Tamashiro A, Miceli MH, Rando C, Tamashiro GA, Villegas MO, Dini AE, Balestrin AE, Diaz JA. Pulmonary artery access embolization in patients with massive hemoptysis in whom bronchial and/or non bronchial systemic artery embolization is contraindicated. Cardiovasc Intervent Radiol. 2008;31(3): 633-7. doi: 10.1007/s00270-007-9265-5
56. Ramakantan R, Bandekar VG, Gandhi MS, Aulakh BG, Deshmukh HL. Massive hemoptysis due to pulmonary tuberculosis: control with bronchial artery embolization. Radiology. 1996;200(3):691-4. doi: 10.1148/radiology.200.3.87569 16
57. Mesurolle B, Lacombe P, Barre O, Qanadli S, Mulot RO, Chagnon S. [Failures and complications of bronchial artery embolization]. Rev Mal Respir. 1996;13(3):217-25. 

В.В. Краева 1, Т.В. Бекетова 2

1 ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский Университет), Москва, Россия;
2 ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой», Москва, Россия

________________________________________________

V.V. Kraeva 1, T.V. Beketova 2

1 I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russia;
2 V.A. Nasonova Scientific and Research Institute of Rheumatology, Moscow, Russia